Search

Your search keyword '"van Aalst, June"' showing total 19 results
Start Over Author "van Aalst, June"
19 results on '"van Aalst, June"'

9. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion

Author

Projectafdeling ALS, ZL Neuromusculaire Ziekten Medisch, Brain, Regenerative Medicine and Stem Cells, De Vocht, Joke, Blommaert, Jeroen, Devrome, Martijn, Radwan, Ahmed, Van Weehaeghe, Donatienne, De Schaepdryver, Maxim, Ceccarini, Jenny, Rezaei, Ahmadreza, Schramm, Georg, van Aalst, June, Chiò, Adriano, Pagani, Marco, Stam, Daphne, Van Esch, Hilde, Lamaire, Nikita, Verhaegen, Marianne, Mertens, Nathalie, Poesen, Koen, van den Berg, Leonard H, van Es, Michael A, Vandenberghe, Rik, Vandenbulcke, Mathieu, Van den Stock, Jan, Koole, Michel, Dupont, Patrick, Van Laere, Koen, Van Damme, Philip, Projectafdeling ALS, ZL Neuromusculaire Ziekten Medisch, Brain, Regenerative Medicine and Stem Cells, De Vocht, Joke, Blommaert, Jeroen, Devrome, Martijn, Radwan, Ahmed, Van Weehaeghe, Donatienne, De Schaepdryver, Maxim, Ceccarini, Jenny, Rezaei, Ahmadreza, Schramm, Georg, van Aalst, June, Chiò, Adriano, Pagani, Marco, Stam, Daphne, Van Esch, Hilde, Lamaire, Nikita, Verhaegen, Marianne, Mertens, Nathalie, Poesen, Koen, van den Berg, Leonard H, van Es, Michael A, Vandenberghe, Rik, Vandenbulcke, Mathieu, Van den Stock, Jan, Koole, Michel, Dupont, Patrick, Van Laere, Koen, and Van Damme, Philip

Published
2020

11. Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion

Author

De Vocht, Joke, primary, Blommaert, Jeroen, additional, Devrome, Martijn, additional, Radwan, Ahmed, additional, Van Weehaeghe, Donatienne, additional, De Schaepdryver, Maxim, additional, Ceccarini, Jenny, additional, Rezaei, Ahmadreza, additional, Schramm, Georg, additional, van Aalst, June, additional, Chiò, Adriano, additional, Pagani, Marco, additional, Stam, Daphne, additional, Van Esch, Hilde, additional, Lamaire, Nikita, additional, Verhaegen, Marianne, additional, Mertens, Nathalie, additional, Poesen, Koen, additional, van den Berg, Leonard H., additional, van Es, Michael A., additional, Vandenberghe, Rik, additional, Vandenbulcke, Mathieu, additional, Van den Stock, Jan, additional, Koole, Michel, additional, Dupont, Patrick, additional, Van Laere, Koen, additional, and Van Damme, Philip, additional

Published
2020
Full Text
View/download PDF

16. (Preprint)

Author

Buffel, Connor, primary, van Aalst, June, additional, Bangels, Anne-Marie, additional, Toelen, Jaan, additional, Allegaert, Karel, additional, Verschueren, Sarah, additional, and Vander Stichele, Geert, additional

Published
2018
Full Text
View/download PDF

17. (Preprint)

Author

Verschueren, Sarah, primary, van Aalst, June, additional, Bangels, Anne-Marie, additional, Toelen, Jaan, additional, Allegaert, Karel, additional, Buffel, Connor, additional, and Vander Stichele, Geert, additional

Published
2018
Full Text
View/download PDF

19. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Author

Koole, Michel, van Aalst, June, Devrome, Martijn, Mertens, Nathalie, Serdons, Kim, Van Laere, Koen, Lacroix, Brigitte, Mercier, Joel, Sciberras, David, and Maguire, Paul

Subjects
*GLYCOPROTEINS, *BRAIN, *GENE expression, *WHITE matter (Nerve tissue), *BLOOD sampling, *POSITRON emission, *DIAGNOSTIC imaging
Abstract

Purpose: A [11C]UCB-J blocking study was performed in healthy volunteers to validate simplified, non-invasive measures for quantifying presynaptic SV2A expression using subcortical white matter as reference tissue.Methods: Ninety minutes dynamic [11C]UCB-J PET scanning with arterial blood sampling was performed in 10 healthy volunteers (8 M/2F; age 27.6 ± 10.0 yrs), before and after administration of a novel chemical entity with selective affinity for SV2A. The centrum semi-ovale (SO) was validated as reference region by comparing baseline and post treatment distribution volume (VT). Using SO as reference tissue, Binding Potential (BPSO) using a Simplified Reference Tissue Model (SRTM, down to 60 min acquisition) and Standardized Uptake Value Ratios (60-90 min post injection - SUVRSO,60-90min) were compared with regional distribution volume ratios (DVR). Next, SV2A occupancy values based on SRTM BPSO and SUVRSO,60-90min were compared to occupancy estimates using regional VT values and a Lassen plot.Results: After pretreatment, regional VT values were reduced significantly except for SO. Highly significant correlations were found between DVR, SRTM BPSO and SUVRSO,60-90min. Compared to DVR, baseline SRTM BPSO showed a small bias (≤ 6.1%) with lower precision for shorter acquisition times, while SUVRSO,60-90min showed 3.5% bias with similar precision. Differences between SV2A occupancy values based on SUVRSO,60-90min and occupancy estimates using VT and a Lassen plot were small but significant, while negligible bias was found for SRTM based occupancy estimates (at least 70 min acquisition).Conclusion: This [11C]UCB-J blocking study validated SO as a suitable reference region for non-invasive quantification of SV2A availability and drug occupancy in the human brain. Accurate quantification can be achieved by using either SUVRSO,60-90min with a 60-90 min PET acquisition or SRTM BPSOwith at least 70 min dynamic PET acquisition. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results